文献速递糖尿病肥胖与代谢综合征

L-精氨酸对南亚与欧洲裔糖尿病前期男性能量代谢、骨骼肌和棕色脂肪组织的影响:一项随机双盲交叉研究

Effect of L-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study.
PubMed 文献 · Diabetologia · 2018-10-30

L-精氨酸未影响基础代谢率、棕色脂肪组织对[18F]FDG的摄取或骨骼肌呼吸;但在欧洲裔中降低OGTT期间血糖AUC(-9%,p<0.01)和胰岛素曲线(-26%,p<0.05),南亚裔无此效应。南亚裔骨骼肌氧化能力低于欧洲裔。

要点

  • L-精氨酸未改善基础代谢率、棕色脂肪活性或骨骼肌呼吸。
  • L-精氨酸仅在欧洲裔中改善糖耐量,南亚裔无获益。
  • 南亚裔糖尿病前期男性骨骼肌氧化能力低于欧洲裔。

核心结论

  • L-精氨酸补充不影响欧洲裔和南亚裔超重糖尿病前期男性的基础代谢率、棕色脂肪[18F]FDG摄取或骨骼肌线粒体呼吸。
  • L-精氨酸改善欧洲裔的糖耐量,但不改善南亚裔的糖耐量。
  • 南亚裔男性的骨骼肌氧化能力低于欧洲裔男性。

研究设计与样本

  • 参与者口服L-精氨酸(9 g/天)或安慰剂6周,干预后行OGTT、间接测热法测基础代谢率、冷诱导[18F]FDG PET-CT评估棕色脂肪活性及骨骼肌活检行离体呼吸能力分析。
  • 主要研究终点为L-精氨酸对棕色脂肪体积和活性的影响。

主要发现

  • L-精氨酸未影响两族裔的基础代谢率、棕色脂肪[18F]FDG摄取或骨骼肌呼吸。
  • 在欧洲裔中,L-精氨酸降低OGTT期间血糖浓度(AUC0-2 h -9%,p<0.01)、胰岛素曲线(AUC0-2 h -26%,p<0.05)和胰岛素峰值浓度(-26%,p<0.05),南亚裔无此变化。
  • 在欧洲裔中,L-精氨酸增强冷诱导葡萄糖氧化(+44%,p<0.05),南亚裔无此效应。
  • 骨骼肌活检显示南亚裔男性多个呼吸状态 consistently 低于欧洲裔男性。

关键数值与推荐

  • 糖尿病前期定义:空腹血糖5.6-6.9 mmol/l或OGTT后2小时血糖7.8-11.1 mmol/l。
  • 纳入标准:年龄40-55岁,BMI 25-35 kg/m2,无2型糖尿病。

临床怎么用

  • L-精氨酸补充可能对欧洲裔糖尿病前期男性的糖代谢有益,但对南亚裔无效。
  • 南亚裔糖尿病前期男性骨骼肌氧化能力较低,可能需要针对性的干预策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Individuals of South Asian origin are at increased risk of developing type 2 diabetes mellitus and associated comorbidities compared with Europids. Disturbances in energy metabolism may contribute to this increased risk. Skeletal muscle and possibly also brown adipose tissue (BAT) are involved in human energy metabolism and nitric oxide (NO) is suggested to play a pivotal role in regulating mitochondrial biogenesis in both tissues. We aimed to investigate the effects of 6 weeks of supplementation with L-arginine, a precursor of NO, on energy metabolism by BAT and skeletal muscle, as well as glucose metabolism in South Asian men compared with men of European descent. METHODS: We included ten Dutch South Asian men (age 46.5 ± 2.8 years, BMI 30.1 ± 1.1 kg/m2) and ten Dutch men of European descent, that were similar with respect to age and BMI, with prediabetes (fasting plasma glucose level 5.6-6.9 mmol/l or plasma glucose levels 2 h after an OGTT 7.8-11.1 mmol/l). Participants took either L-arginine (9 g/day) or placebo orally for 6 weeks in a randomised double-blind crossover study. Participants were eligible to participate in the study when they were aged between 40 and 55 years, had a BMI between 25 and 35 kg/m2 and did not have type 2 diabetes. Furthermore, ethnicity was defined as having four grandparents of South Asian or white European origin, respectively. Blinding of treatment was done by the pharmacy (Hankintatukku) and an independent researcher from Leiden University Medical Center randomly assigned treatments by providing a coded list. All people involved in the study as well as participants were blinded to group assignment. After each intervention, glucose tolerance was determined by OGTT and basal metabolic rate (BMR) was determined by indirect calorimetry; BAT activity was assessed by cold-induced [18F]fluorodeoxyglucose ([18F]FDG) positron emission tomography-computed tomography scanning. In addition, a fasting skeletal muscle biopsy was taken and analysed ex vivo for respiratory capacity using a multisubstrate protocol. The primary study endpoint was the effect of L-arginine on BAT volume and activity. RESULTS: L-Arginine did not affect BMR, [18F]FDG uptake by BAT or skeletal muscle respiration in either ethnicity. During OGTT, L-arginine lowered plasma glucose concentrations (AUC0-2 h - 9%, p < 0.01), insulin excursion (AUC0-2 h - 26%, p < 0.05) and peak insulin concentrations (-26%, p < 0.05) in Europid but not South Asian men. This coincided with enhanced cold-induced glucose oxidation (+44%, p < 0.05) in Europids only. Of note, in skeletal muscle biopsies several respiration states were consistently lower in South Asian men compared with Europid men. CONCLUSIONS/INTERPRETATION: L-Arginine supplementation does not affect BMR, [18F]FDG uptake by BAT, or skeletal muscle mitochondrial respiration in Europid and South Asian overweight and prediabetic men. However, L-arginine improves glucose tolerance in Europids but not in South Asians. Furthermore, South Asian men have lower skeletal muscle oxidative capacity than men of European descent. FUNDING: This study was funded by the EU FP7 project DIABAT, the Netherlands Organization for Scientific Research, the Dutch Diabetes Research Foundation and the Dutch Heart Foundation. TRIAL REGISTRATION: ClinicalTrials.gov NCT02291458.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Boon MR, Hanssen MJW, Brans B, et al. Effect of L-arginine on energy metabolism, skeletal muscle and brown adipose tissue in South Asian and Europid prediabetic men: a randomised double-blinded crossover study. Diabetologia. 2018. PMID: 30377712. doi:10.1007/s00125-018-4752-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。